PMC:3245220 / 519-816 JSONTXT

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T451","span":{"begin":188,"end":192},"obj":"P17252"},{"id":"T452","span":{"begin":250,"end":254},"obj":"P17252"},{"id":"T453","span":{"begin":270,"end":274},"obj":"P17252"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T468","span":{"begin":195,"end":204},"obj":"Negative_regulation"},{"id":"T469","span":{"begin":195,"end":204},"obj":"Negative_regulation"},{"id":"T470","span":{"begin":214,"end":228},"obj":"Gene_expression"},{"id":"T480","span":{"begin":188,"end":192},"obj":"Protein"},{"id":"T491","span":{"begin":193,"end":194},"obj":"Protein"},{"id":"T494","span":{"begin":232,"end":254},"obj":"Protein"},{"id":"T495","span":{"begin":270,"end":280},"obj":"Protein"}],"relations":[{"id":"R411","pred":"themeOf","subj":"T480","obj":"T468"},{"id":"R415","pred":"themeOf","subj":"T491","obj":"T469"},{"id":"R417","pred":"themeOf","subj":"T494","obj":"T470"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T747","span":{"begin":118,"end":142},"obj":"Protein"},{"id":"T748","span":{"begin":144,"end":147},"obj":"Protein"},{"id":"T749","span":{"begin":188,"end":194},"obj":"Protein"},{"id":"T750","span":{"begin":232,"end":265},"obj":"Protein"},{"id":"T751","span":{"begin":270,"end":288},"obj":"Protein"},{"id":"T752","span":{"begin":289,"end":294},"obj":"Protein"},{"id":"T754","span":{"begin":214,"end":228},"obj":"Gene_expression"},{"id":"T755","span":{"begin":214,"end":228},"obj":"Gene_expression"},{"id":"T756","span":{"begin":214,"end":228},"obj":"Gene_expression"},{"id":"T757","span":{"begin":214,"end":228},"obj":"Gene_expression"}],"relations":[{"id":"R525","pred":"themeOf","subj":"T747","obj":"T754"},{"id":"R526","pred":"themeOf","subj":"T748","obj":"T755"},{"id":"R527","pred":"themeOf","subj":"T750","obj":"T756"},{"id":"R528","pred":"themeOf","subj":"T751","obj":"T757"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"events-check-again","denotations":[{"id":"T705","span":{"begin":188,"end":192},"obj":"Protein"},{"id":"T706","span":{"begin":193,"end":194},"obj":"Protein"},{"id":"T707","span":{"begin":195,"end":204},"obj":"Negative_regulation"},{"id":"T708","span":{"begin":195,"end":204},"obj":"Negative_regulation"},{"id":"T709","span":{"begin":214,"end":228},"obj":"Gene_expression"},{"id":"T710","span":{"begin":232,"end":254},"obj":"Protein"},{"id":"T711","span":{"begin":270,"end":280},"obj":"Protein"}],"relations":[{"id":"R501","pred":"themeOf","subj":"T705","obj":"T707"},{"id":"R502","pred":"themeOf","subj":"T706","obj":"T708"},{"id":"R503","pred":"themeOf","subj":"T710","obj":"T709"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"GO-CC","denotations":[{"id":"T533","span":{"begin":93,"end":97},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"GO-MF","denotations":[{"id":"T528","span":{"begin":144,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T529","span":{"begin":188,"end":192},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T530","span":{"begin":250,"end":254},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T531","span":{"begin":270,"end":274},"obj":"http://purl.obolibrary.org/obo/GO_0004697"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"GO-BP","denotations":[{"id":"T515","span":{"begin":144,"end":147},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T516","span":{"begin":188,"end":192},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T517","span":{"begin":250,"end":254},"obj":"http://purl.obolibrary.org/obo/GO_0004697"},{"id":"T518","span":{"begin":270,"end":274},"obj":"http://purl.obolibrary.org/obo/GO_0004697"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"pmc-enju-pas","denotations":[{"id":"T321","span":{"begin":13,"end":21},"obj":"NN"},{"id":"T322","span":{"begin":22,"end":24},"obj":"IN"},{"id":"T323","span":{"begin":25,"end":30},"obj":"JJ"},{"id":"T324","span":{"begin":31,"end":47},"obj":"JJ"},{"id":"T325","span":{"begin":48,"end":59},"obj":"NN"},{"id":"T326","span":{"begin":60,"end":61},"obj":"-LRB-"},{"id":"T327","span":{"begin":61,"end":65},"obj":"NN"},{"id":"T328","span":{"begin":65,"end":66},"obj":"-RRB-"},{"id":"T329","span":{"begin":67,"end":70},"obj":"CC"},{"id":"T330","span":{"begin":71,"end":74},"obj":"DT"},{"id":"T331","span":{"begin":75,"end":81},"obj":"JJ"},{"id":"T332","span":{"begin":82,"end":92},"obj":"NN"},{"id":"T333","span":{"begin":93,"end":97},"obj":"NN"},{"id":"T334","span":{"begin":98,"end":102},"obj":"NN"},{"id":"T335","span":{"begin":103,"end":106},"obj":"NN"},{"id":"T336","span":{"begin":107,"end":112},"obj":"CD"},{"id":"T337","span":{"begin":114,"end":117},"obj":"DT"},{"id":"T338","span":{"begin":118,"end":125},"obj":"JJ"},{"id":"T339","span":{"begin":126,"end":133},"obj":"NN"},{"id":"T340","span":{"begin":134,"end":140},"obj":"NN"},{"id":"T341","span":{"begin":141,"end":142},"obj":"NN"},{"id":"T342","span":{"begin":143,"end":144},"obj":"-LRB-"},{"id":"T343","span":{"begin":144,"end":147},"obj":"NN"},{"id":"T344","span":{"begin":147,"end":148},"obj":"-RRB-"},{"id":"T345","span":{"begin":149,"end":158},"obj":"NN"},{"id":"T346","span":{"begin":159,"end":169},"obj":"NN"},{"id":"T347","span":{"begin":169,"end":170},"obj":"-COMMA-"},{"id":"T348","span":{"begin":171,"end":174},"obj":"DT"},{"id":"T349","span":{"begin":175,"end":187},"obj":"JJ"},{"id":"T350","span":{"begin":188,"end":194},"obj":"NN"},{"id":"T351","span":{"begin":195,"end":204},"obj":"NN"},{"id":"T352","span":{"begin":205,"end":212},"obj":"NN"},{"id":"T353","span":{"begin":212,"end":213},"obj":"-COMMA-"},{"id":"T354","span":{"begin":214,"end":228},"obj":"NN"},{"id":"T355","span":{"begin":229,"end":231},"obj":"IN"},{"id":"T356","span":{"begin":232,"end":240},"obj":"JJ"},{"id":"T357","span":{"begin":241,"end":249},"obj":"JJ"},{"id":"T358","span":{"begin":250,"end":254},"obj":"NN"},{"id":"T359","span":{"begin":255,"end":265},"obj":"NN"},{"id":"T360","span":{"begin":266,"end":269},"obj":"CC"},{"id":"T361","span":{"begin":270,"end":274},"obj":"NN"},{"id":"T362","span":{"begin":275,"end":280},"obj":"NN"},{"id":"T363","span":{"begin":281,"end":288},"obj":"VB"},{"id":"T364","span":{"begin":289,"end":294},"obj":"NN"}],"relations":[{"id":"R286","pred":"arg1Of","subj":"T321","obj":"T322"},{"id":"R287","pred":"arg1Of","subj":"T321","obj":"T329"},{"id":"R288","pred":"arg2Of","subj":"T325","obj":"T322"},{"id":"R289","pred":"arg1Of","subj":"T325","obj":"T323"},{"id":"R290","pred":"arg1Of","subj":"T325","obj":"T324"},{"id":"R291","pred":"arg1Of","subj":"T325","obj":"T326"},{"id":"R292","pred":"arg2Of","subj":"T327","obj":"T326"},{"id":"R293","pred":"arg3Of","subj":"T328","obj":"T326"},{"id":"R295","pred":"arg2Of","subj":"T335","obj":"T329"},{"id":"R296","pred":"arg1Of","subj":"T335","obj":"T330"},{"id":"R297","pred":"arg1Of","subj":"T335","obj":"T331"},{"id":"R298","pred":"arg1Of","subj":"T335","obj":"T332"},{"id":"R299","pred":"arg1Of","subj":"T335","obj":"T333"},{"id":"R300","pred":"arg1Of","subj":"T335","obj":"T334"},{"id":"R301","pred":"arg1Of","subj":"T335","obj":"T336"},{"id":"R302","pred":"arg1Of","subj":"T341","obj":"T338"},{"id":"R303","pred":"arg1Of","subj":"T341","obj":"T339"},{"id":"R304","pred":"arg1Of","subj":"T341","obj":"T340"},{"id":"R305","pred":"arg1Of","subj":"T341","obj":"T342"},{"id":"R306","pred":"arg2Of","subj":"T343","obj":"T342"},{"id":"R307","pred":"arg3Of","subj":"T344","obj":"T342"},{"id":"R308","pred":"arg1Of","subj":"T346","obj":"T337"},{"id":"R309","pred":"arg1Of","subj":"T346","obj":"T341"},{"id":"R310","pred":"arg1Of","subj":"T346","obj":"T345"},{"id":"R311","pred":"arg1Of","subj":"T346","obj":"T347"},{"id":"R312","pred":"arg1Of","subj":"T346","obj":"T353"},{"id":"R313","pred":"arg2Of","subj":"T352","obj":"T347"},{"id":"R314","pred":"arg1Of","subj":"T352","obj":"T348"},{"id":"R315","pred":"arg1Of","subj":"T352","obj":"T349"},{"id":"R316","pred":"arg1Of","subj":"T352","obj":"T350"},{"id":"R317","pred":"arg1Of","subj":"T352","obj":"T351"},{"id":"R318","pred":"arg1Of","subj":"T353","obj":"T360"},{"id":"R319","pred":"arg2Of","subj":"T354","obj":"T353"},{"id":"R320","pred":"arg1Of","subj":"T354","obj":"T355"},{"id":"R321","pred":"arg2Of","subj":"T359","obj":"T355"},{"id":"R322","pred":"arg1Of","subj":"T359","obj":"T356"},{"id":"R323","pred":"arg1Of","subj":"T359","obj":"T357"},{"id":"R324","pred":"arg1Of","subj":"T359","obj":"T358"},{"id":"R325","pred":"arg1Of","subj":"T360","obj":"T363"},{"id":"R326","pred":"arg2Of","subj":"T362","obj":"T360"},{"id":"R327","pred":"arg1Of","subj":"T362","obj":"T361"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T128","span":{"begin":13,"end":21},"obj":"NN"},{"id":"T129","span":{"begin":22,"end":24},"obj":"IN"},{"id":"T130","span":{"begin":25,"end":30},"obj":"JJ"},{"id":"T131","span":{"begin":31,"end":47},"obj":"JJ"},{"id":"T132","span":{"begin":48,"end":59},"obj":"NNS"},{"id":"T133","span":{"begin":60,"end":61},"obj":"-LRB-"},{"id":"T134","span":{"begin":61,"end":65},"obj":"NNS"},{"id":"T135","span":{"begin":65,"end":66},"obj":"-RRB-"},{"id":"T136","span":{"begin":67,"end":70},"obj":"CC"},{"id":"T137","span":{"begin":71,"end":74},"obj":"DT"},{"id":"T138","span":{"begin":75,"end":81},"obj":"NN"},{"id":"T139","span":{"begin":82,"end":92},"obj":"NN"},{"id":"T140","span":{"begin":93,"end":97},"obj":"NN"},{"id":"T141","span":{"begin":98,"end":102},"obj":"NN"},{"id":"T142","span":{"begin":103,"end":106},"obj":"NNP"},{"id":"T143","span":{"begin":107,"end":112},"obj":"CD"},{"id":"T144","span":{"begin":112,"end":113},"obj":"."},{"id":"T145","span":{"begin":114,"end":117},"obj":"DT"},{"id":"T146","span":{"begin":118,"end":125},"obj":"JJ"},{"id":"T147","span":{"begin":126,"end":133},"obj":"NN"},{"id":"T148","span":{"begin":134,"end":140},"obj":"NN"},{"id":"T149","span":{"begin":141,"end":142},"obj":"NNP"},{"id":"T150","span":{"begin":143,"end":144},"obj":"-LRB-"},{"id":"T151","span":{"begin":144,"end":147},"obj":"NNP"},{"id":"T152","span":{"begin":147,"end":148},"obj":"-RRB-"},{"id":"T153","span":{"begin":149,"end":158},"obj":"NN"},{"id":"T154","span":{"begin":159,"end":169},"obj":"NN"},{"id":"T155","span":{"begin":169,"end":170},"obj":","},{"id":"T156","span":{"begin":171,"end":174},"obj":"DT"},{"id":"T157","span":{"begin":175,"end":187},"obj":"JJ"},{"id":"T158","span":{"begin":188,"end":192},"obj":"NNP"},{"id":"T159","span":{"begin":192,"end":193},"obj":"NN"},{"id":"T160","span":{"begin":193,"end":194},"obj":"NN"},{"id":"T161","span":{"begin":195,"end":204},"obj":"NN"},{"id":"T162","span":{"begin":205,"end":212},"obj":"NNP"},{"id":"T163","span":{"begin":212,"end":213},"obj":","},{"id":"T164","span":{"begin":214,"end":228},"obj":"NN"},{"id":"T165","span":{"begin":229,"end":231},"obj":"IN"},{"id":"T166","span":{"begin":232,"end":240},"obj":"JJ"},{"id":"T167","span":{"begin":241,"end":249},"obj":"JJ"},{"id":"T168","span":{"begin":250,"end":254},"obj":"NNP"},{"id":"T169","span":{"begin":255,"end":265},"obj":"NNS"},{"id":"T170","span":{"begin":266,"end":269},"obj":"CC"},{"id":"T171","span":{"begin":270,"end":274},"obj":"NNP"},{"id":"T172","span":{"begin":275,"end":280},"obj":"NNP"},{"id":"T173","span":{"begin":281,"end":288},"obj":"VBD"},{"id":"T174","span":{"begin":289,"end":294},"obj":"JJ"}],"relations":[{"id":"R97","pred":"prep","subj":"T129","obj":"T128"},{"id":"R98","pred":"amod","subj":"T130","obj":"T132"},{"id":"R99","pred":"amod","subj":"T131","obj":"T132"},{"id":"R100","pred":"pobj","subj":"T132","obj":"T129"},{"id":"R101","pred":"punct","subj":"T133","obj":"T134"},{"id":"R102","pred":"appos","subj":"T134","obj":"T132"},{"id":"R105","pred":"det","subj":"T137","obj":"T142"},{"id":"R106","pred":"nmod","subj":"T138","obj":"T141"},{"id":"R107","pred":"compound","subj":"T139","obj":"T141"},{"id":"R108","pred":"compound","subj":"T140","obj":"T141"},{"id":"R109","pred":"compound","subj":"T141","obj":"T142"},{"id":"R111","pred":"nummod","subj":"T143","obj":"T142"},{"id":"R113","pred":"det","subj":"T145","obj":"T147"},{"id":"R114","pred":"amod","subj":"T146","obj":"T147"},{"id":"R115","pred":"nsubj","subj":"T147","obj":"T173"},{"id":"R116","pred":"compound","subj":"T148","obj":"T149"},{"id":"R117","pred":"appos","subj":"T149","obj":"T147"},{"id":"R118","pred":"punct","subj":"T150","obj":"T149"},{"id":"R119","pred":"appos","subj":"T151","obj":"T149"},{"id":"R120","pred":"punct","subj":"T152","obj":"T149"},{"id":"R121","pred":"compound","subj":"T153","obj":"T154"},{"id":"R122","pred":"appos","subj":"T154","obj":"T149"},{"id":"R123","pred":"punct","subj":"T155","obj":"T149"},{"id":"R124","pred":"det","subj":"T156","obj":"T162"},{"id":"R125","pred":"amod","subj":"T157","obj":"T162"},{"id":"R126","pred":"compound","subj":"T158","obj":"T162"},{"id":"R127","pred":"compound","subj":"T159","obj":"T162"},{"id":"R128","pred":"compound","subj":"T160","obj":"T162"},{"id":"R129","pred":"compound","subj":"T161","obj":"T162"},{"id":"R130","pred":"appos","subj":"T162","obj":"T149"},{"id":"R131","pred":"punct","subj":"T163","obj":"T162"},{"id":"R132","pred":"appos","subj":"T164","obj":"T162"},{"id":"R133","pred":"prep","subj":"T165","obj":"T164"},{"id":"R134","pred":"amod","subj":"T166","obj":"T169"},{"id":"R135","pred":"amod","subj":"T167","obj":"T169"},{"id":"R136","pred":"compound","subj":"T168","obj":"T169"},{"id":"R137","pred":"pobj","subj":"T169","obj":"T165"},{"id":"R138","pred":"cc","subj":"T170","obj":"T169"},{"id":"R139","pred":"compound","subj":"T171","obj":"T172"},{"id":"R140","pred":"nsubj","subj":"T172","obj":"T173"},{"id":"R141","pred":"ROOT","subj":"T173","obj":"T173"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}

{"project":"test2","denotations":[{"id":"T31","span":{"begin":188,"end":192},"obj":"Protein"},{"id":"T32","span":{"begin":193,"end":194},"obj":"Protein"},{"id":"T33","span":{"begin":195,"end":204},"obj":"Negative_regulation"},{"id":"T34","span":{"begin":232,"end":254},"obj":"Protein"},{"id":"T35","span":{"begin":270,"end":280},"obj":"Protein"}],"relations":[{"id":"R18","pred":"themeOf","subj":"T31","obj":"T33"},{"id":"R19","pred":"themeOf","subj":"T32","obj":"T33"}],"text":"nscriptional activity in human monocyte-derived macrophages (MDMs) and the murine macrophage cell line RAW 264.7. The general protein kinase C (PKC) inhibitor Ro-31-8220, the conventional PKCα/β inhibitor Gö-6976, overexpression of dominant negative PKCα constructs and PKCα siRNA reduced NF-κB ac"}